Committee Membership Information
Dr. Jane E. Henney
Jane E. Henney (Chair) has held a series of senior health policy leadership positions in the public sector and recently left the University of Cincinnati College of Medicine where she was a professor of medicine. Beginning in 1980, Dr. Henney served for five years as the Deputy Director of the National Cancer Institute. Subsequently, she joined the University of Kansas Medical Center as Vice Chancellor of Health Programs, and, for 18 months, interim dean of the School of Medicine. She then served as Deputy Commissioner for Operations of the U.S. Food and Drug Administration, where she stayed until assuming the position as the first Vice President for Health Sciences at the University of New Mexico. In 1998, she was nominated by President Bill Clinton and confirmed by the U.S. Senate as the Commissioner of the U.S. Food and Drug Administration. She served in this capacity until January 2001. After leaving FDA, she was appointed a senior scholar in residence at the Association of Academic Health Centers. From July 2003 until the beginning of 2008, she served as Senior Vice President and Provost for Health Affairs at the University of Cincinnati. Dr. Henney is a member of the Board of Directors of AmerisourceBergen Corporation and CIGNA in Philadelphia, Pennsylvania, and Cubist Pharmaceuticals in Lexington, Massachusetts. She has received many honors and awards in her field, including election to the Society of Medical Administrators and honorary membership in the American College of Health Care Executives. She is a recipient of the Excellence in Women's Health Award from the Jacobs Institute, the Public Health Leadership Award from the National Organization of Rare Disorders, and, on two separate occasions, the Public Health Service Commendation Medal. She is a member of the Institute of Medicine and has served as a member and chair of numerous National Academies committees. Dr. Henney earned an MD from Indiana University and completed her subspecialty training in medical oncology at the M.D. Anderson Hospital and Tumor Institute and the National Cancer Institute.
Dr. Judith B. Klotz
University of Medicine and Dentistry of New Jersey
Judith B. Klotz is an adjunct associate professor at the Drexel University School of Public Health and holds the same appointment at the University of Medicine and Dentistry of New Jersey School of Public Health. Previously, she was program manager of the cancer surveillance and environmental epidemiology programs at the New Jersey Department of Health. Her research interests are in epidemiologic studies of cancer incidence and reproductive outcomes, gene-environment interactions, evaluation of biological exposures to environmental contaminants, and the application of health risk assessment and epidemiology to public policy. Dr. Klotz served as a member of the National Research Council Committee to Review Possible Toxic Effects from Past Environmental Contamination at Fort Detrick and Subcommittee on Fluoride in Drinking Water. She received her DrPH in environmental health sciences from Columbia University School of Public Health.
Dr. Xiaomei Ma
Xiaomei Ma is an associate professor in the Department of Chronic Disease Epidemiology at the Yale School of Public Health. Her research interests are in the epidemiology of hematological malignancies, including leukemia, myelodysplastic syndromes, and lymphoma. Specifically, she is interested in environmental and genetic factors in the etiology of childhood leukemia, the outcomes of myelodysplastic syndromes, and methodological issues in the design of various types of epidemiologic studies. Dr. Ma served as a member of the National Research Council Committee on Contaminated Drinking Water at Camp Lejeune. She received a PhD in epidemiology from the University of California, Berkeley.
Dr. Charles G. Plopper
University of California, Davis
Charles G. Plopper is professor emeritus in the School of Veterinary Medicine at the University of California, Davis. His research interests include pulmonary cellular and developmental biology, injury and repair responses of lung cells to inhaled and bioactivated toxicants, lung toxicology, lung cellular pathobiology, and cell biology and anatomy. Dr. Plopper has been an adviser to the National Institutes of Health, the U.S. Environmental Protection Agency, and the California Environmental Protection Agency, and he has served as a visiting scientist at the National Cancer Institute. He has been recognized for career achievements by the Society of Toxicology and received the Pfizer Award for Research Excellence twice at the University of California, Davis. He has also received the Norden Distinguished Teaching Award from the School of Veterinary Medicine and the Meritorious Teaching Award from the University of Hawaii. Dr. Plopper earned a PhD in anatomy from the University of California, Davis.
Dr. Weiquiang (John) Zhao
The Ohio State University
Weiqiang (John) Zhao is an assistant professor of pathology and director of the Pathology Core Facility at Ohio State University. His research interests include the investigation of molecular mechanisms of leukemogenesis, the determination of prognostic genetic abnormalities of leukemia and lymphoma cells, and the elucidation of host genetic determinates of treatment response and late effects. He is board certified by the American Board of Pathology, the American Board of Hematopathology, and the American Board of Molecular Genetic Pathology. Dr. Zhao earned an MD from Hunan Medical University in Changsha, China, and a PhD in molecular and cell biology from Tulane University.
Dr. Howard E. Rockette
University of Pittsburgh
Howard E. Rockette is a professor emeritus in the Department of Biostatistics at the University of Pittsburgh School of Public Health. His research has focused on the development and application of statistical methods for problems in the areas of clinical trials, occupational and environmental epidemiology, and the evaluation of radiological imaging systems. His research in occupational and environmental health has included estimation of cancer risk for various occupational groups, including coal miners, steelworkers, and aluminum reduction plant workers. Dr. Rockette has served terms as the primary statistical reviewer for Annals of Epidemiology and for Cleft Palate Craniofacial Journal and has served on the editorial board of Academic Radiology. He has served on study sections for the National Institute of Occupational Safety and Health and the National Institute of Environmental Health Sciences, he has served as the president of the risk section of the American Statistical Association, and he is currently a member of the Institute of Medicine Committee on the Review of the Department of Labor?s Site Exposure Matrix (SEM) Database. Dr. Rockette earned a PhD in statistics at The Pennsylvania State University.
Dr. Stephen M. Roberts
University of Florida
Stephen M. Roberts is a professor and director of the Center for Environmental and Human Toxicology in the College of Veterinary Medicine at the University of Florida. He has previously served on the faculties of the College of Pharmacy at the University of Cincinnati and the College of Medicine at the University of Arkansas. His research interests include mechanisms of drug and chemical toxicity, cell defense mechanisms against toxicity, toxicokinetics, bioavailability of environmental contaminants, risk assessment, and novel gene therapy approaches for cancer. Dr. Roberts earned a PhD in pharmacology from the University of Utah College of Medicine.
Dr. Ivan Rusyn
The University of North Carolina at Chapel Hill
Ivan Rusyn is a professor in the Department of Environmental Sciences and Engineering in the School of Public Health at the University of North Carolina (UNC) at Chapel Hill. He directs the Laboratory of Environmental Genomics and the Carolina Center for Computational Toxicology in the Gillings School of Global Public Health at UNC-Chapel Hill. He is a member of the Lineberger Comprehensive Cancer Center, the Center for Environmental Health and Susceptibility, the Bowles Center for Alcohol Studies, and the Carolina Center for Genome Sciences. Dr. Rusyn's laboratory focuses on the mechanisms of action of environmental toxicants, the genetic determinants of the susceptibility to toxicant-induced injury, and computational toxicology. He has served on several National Research Council committees and is currently a member of the Committee on Use of Emerging Science for Environmental Health Decisions and the Committee on Toxicology. Dr. Rusyn received his MD from Ukrainian State Medical University in Kiev and his PhD in toxicology from UNC-Chapel Hill.
Dr. John B. Morris
University of Connecticut
John B. Morris is the Board of Trustees Distinguished Professor, a professor of pharmacology and toxicology, and Assistant Dean for Research in the Department of Pharmaceutical Sciences at the University of Connecticut School of Pharmacy. His research focuses on toxicity of inhaled irritant vapors, irritants and asthma, regional uptake and metabolism of inspired vapors, physiologically based pharmacokinetic modeling, and risk assessment. Dr. Morris has served on the editorial boards for Toxicological Sciences and Inhalation Toxicology and on advisory panels for the National Institutes of Health, the U.S. Environmental Protection Agency, and the Department of Energy. He has also served as a member of the National Research Council Committee on Emergency and Continuous Exposure Guidance Levels for Selected Submarine Contaminants. Dr. Morris earned a PhD in toxicology from the University of Rochester.
Dr. Arthur P. Grollman
State University of New York at Stony Brook
Arthur P. Grollman is the Distinguished Professor of Pharmacological Sciences, the Evelyn G. Glick Professor of Experimental Medicine, and director of the Zickler Laboratory of Chemical Biology at the State University of New York at Stony Brook. His research interests focus on the biologic consequences of DNA damage as they relate to molecular mechanisms of DNA replication, mutagenesis, and DNA repair. Research in his laboratory has been instrumental in establishing the mechanism of action of the antitumor agent bleomycin and in defining the biochemical pathway that protects cells against mutations produced by oxidative DNA damage. He has received an American Cancer Society Scholarship Award, a MERIT award from the National Cancer Institute, and has been elected to the Johns Hopkins Society of Scholars. Dr. Grollman earned an MD from the Johns Hopkins School of Medicine.
Dr. John C. Bailar, III
The University of Chicago
John C. Bailar III is an emeritus professor of the University of Chicago. His research interests have included trends in cancer, assessing health risks, such as the risks of new chemicals, and misconduct in science. His areas of expertise include statistics, biostatistics, epidemiology, and environmental and occupational hazards. Dr. Bailar worked at the National Cancer Institute for 22 years, and he has held academic appointments at Harvard University, McGill University, and the University of Chicago. For 11 years, he was the statistical consultant and a member of the editorial board for The New England Journal of Medicine. He was a MacArthur Fellow from 1990 to 1995, and was elected to both the Institute of Medicine and the International Statistical Institute. Dr. Bailar has served as a member and as chair of many National Academies committees. His most recent committee work has included participation in the Committee on the Analysis of Cancer Risks in Populations Near Nuclear Facilities ? Phase I and the Committee to Review Possible Toxic Effects from Past Environmental Containment at Fort Detrick. Dr. Bailar earned an MD from Yale and a PhD in statistics from American University.